Founder
Conor H. Murray, PhD is a neuroscientist at the University of California, Los Angeles. His published work includes the neurobiology of substance use disorders and studies of psychedelic compounds as novel therapeutic agents. He has created Psynautics as a research platform to address gaps in the fields of neuroscience, pharmacology, and the science of consciousness.
conor@psynautics.com
Clinical Relations Director
Jyoti Gill, PharmD, MBA, brings a wealth of expertise and leadership from the healthcare technology startup landscape. Jyoti has held key roles scaling organizations and providing customer value at Kalderos, Olive AI, and TailorMed. With Psynautics, Jyoti fosters strategic partnerships to deliver innovative and impactful solutions within the dynamic healthcare industry.
jyoti@psynautics.com
Project Manager
Michael Angyus, MSc is a graduate from Imperial College London with three years of experience in psychedelic research. His work aims to develop translational tools to aid in delivery of psychedelic healing. He has worked with top researchers to produce psychometric scales and EEG based measures of psychedelic effects. With Psynautics, Michael is fostering strategic relationships and conducting research within the Oregon Psilocybin Services industry, ultimately tapping this growing data source to develop translational tools for psychedelic healing.
Analyst
Daria Dikovskaya is a graduate student at Imperial College London.